Optimal dosing regimen of CD73 blockade improves tumor response to radiotherapy through iCOS downregulation

BACKGROUND: Irradiation (IR) and immune checkpoint inhibitor (ICI) combination is a promising treatment modality. However, local and distance treatment failure and resistance can occur. To counteract this resistance, several studies propose CD73, an ectoenzyme, as a potential target to improve the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Meziani, Lydia, Gerbé de Thoré, Marine, Clémenson, Céline, Liu, Winchygn, Laurent, Pierre-Antoine, Mondini, Michele, Vozenin, Marie-Catherine, Deutsch, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255154/
https://www.ncbi.nlm.nih.gov/pubmed/37270182
http://dx.doi.org/10.1136/jitc-2023-006846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255154/
https://www.ncbi.nlm.nih.gov/pubmed/37270182
http://dx.doi.org/10.1136/jitc-2023-006846

Ejemplares similares